Nant Capital, Llc - Net Worth and Insider Trading

Nant Capital, Llc Net Worth

The estimated net worth of Nant Capital, Llc is at least $94,498 dollars as of 2024-11-06. Nant Capital, Llc is the 10% Owner of Heliogen Inc and owns about 67,020 shares of Heliogen Inc (HLGN) stock worth over $94,498. Details can be seen in Nant Capital, Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nant Capital, Llc has not made any transactions after 2024-02-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Nant Capital, Llc

Nant Capital, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nant Capital, Llc owns 6 companies in total, including Benitec Biopharma Inc (BNTC) , Tribune Publishing Co (TPCO) , and NantHealth Inc (NHIQ) among others .

Click here to see the complete history of Nant Capital, Llc’s form 4 insider trades.

Insider Ownership Summary of Nant Capital, Llc

Ticker	Comapny	Transaction Date	Type of Owner
BNTC	Benitec Biopharma Inc	2020-04-15	10 percent owner
TPCO	Tribune Publishing Co	2016-06-01	10 percent owner
NHIQ	NantHealth Inc	2021-04-27	10 percent owner
		2024-02-15	10 percent owner
		2021-12-30	10 percent owner
		2023-09-11	10 percent owner

Nant Capital, Llc Latest Holdings Summary

Nant Capital, Llc currently owns a total of 1 stock. Nant Capital, Llc owns 67,020 shares of Heliogen Inc (HLGN) as of February 15, 2024, with a value of $94,498.

Latest Holdings of Nant Capital, Llc

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HLGN	Heliogen Inc	2024-02-15	67,020	1.41	94,498

Holding Weightings of Nant Capital, Llc

Nant Capital, Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Nant Capital, Llc has made a total of 11 transactions in Heliogen Inc (HLGN) over the past 5 years, including 11 buys and 0 sells. The most-recent trade in Heliogen Inc is the acquisition of 442,298 shares on February 15, 2024, which cost Nant Capital, Llc around $672,293.

Insider Trading History of Nant Capital, Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nant Capital, Llc Trading Performance

GuruFocus tracks the stock performance after each of Nant Capital, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nant Capital, Llc is -25.56%. GuruFocus also compares Nant Capital, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nant Capital, Llc within 3 months outperforms 2 times out of 11 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Nant Capital, Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Nant Capital, Llc

Average Return

Average return per transaction

Outperforming Transactions

0 out of 10 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	4.04
Relative Return to S&P 500(%)	2.46

Nant Capital, Llc Ownership Network

Ownership Network List of Nant Capital, Llc

No Data

Ownership Network Relation of Nant Capital, Llc

Nant Capital, Llc Owned Company Details

What does Benitec Biopharma Inc do?

Who are the key executives at Benitec Biopharma Inc?

Nant Capital, Llc is the 10 percent owner of Benitec Biopharma Inc. Other key executives at Benitec Biopharma Inc include director & Executive Director Megan Boston , 10 percent owner Steven Michael Oliveira , and 10 percent owner Patrick Soon-shiong .

Benitec Biopharma Inc (BNTC) Insider Trades Summary

Over the past 18 months, Nant Capital, Llc made no insider transaction in Benitec Biopharma Inc (BNTC). Other recent insider transactions involving Benitec Biopharma Inc (BNTC) include a net purchase of 51,813 shares made by J Kevin Buchi , and a net purchase of 25,907 shares made by Megan Boston .

In summary, during the past 3 months, insiders sold 0 shares of Benitec Biopharma Inc (BNTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Benitec Biopharma Inc (BNTC) were sold and 77,720 shares were bought by its insiders, resulting in a net purchase of 77,720 shares.

Benitec Biopharma Inc (BNTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Benitec Biopharma Inc Insider Transactions

No Available Data

What does Tribune Publishing Co do?

Who are the key executives at Tribune Publishing Co?

Nant Capital, Llc is the 10 percent owner of Tribune Publishing Co. Other key executives at Tribune Publishing Co include Interim CFO Michael Norman Lavey , EVP and General Counsel Julie K. Xanders , and Chief Executive Officer Terry Jimenez .

Tribune Publishing Co (TPCO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tribune Publishing Co (TPCO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tribune Publishing Co (TPCO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tribune Publishing Co (TPCO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tribune Publishing Co Insider Transactions

No Available Data

What does NantHealth Inc do?

Who are the key executives at NantHealth Inc?

Nant Capital, Llc is the 10 percent owner of NantHealth Inc. Other key executives at NantHealth Inc include director & 10 percent owner & Chief Executive Officer Rao Haris Naseem , 10 percent owner Summus Holdings Llc , and Chief Operating Officer Ronald Allen Louks .

NantHealth Inc (NHIQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NantHealth Inc (NHIQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NantHealth Inc (NHIQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NantHealth Inc (NHIQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

NantHealth Inc Insider Transactions

No Available Data

What does Heliogen Inc do?

Who are the key executives at Heliogen Inc?

Nant Capital, Llc is the 10 percent owner of Heliogen Inc. Other key executives at Heliogen Inc include director & Chief Executive Officer William Gross , CFO and Head of Strategy Sagar Kurada , and Chief Commercial Officer Thomas P. Doyle .

Heliogen Inc (HLGN) Insider Trades Summary

Over the past 18 months, Nant Capital, Llc made 7 insider transaction in Heliogen Inc (HLGN) with a net purchase of 7,091,584. Other recent insider transactions involving Heliogen Inc (HLGN) include a net sale of 4,378,736 shares made by William Gross , a net sale of 6,800,000 shares made by Prime Movers Lab Fund I Lp , and a net sale of 30,441 shares made by Christiana Obiaya .

In summary, during the past 3 months, insiders sold 0 shares of Heliogen Inc (HLGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 750,281 shares of Heliogen Inc (HLGN) were sold and 639,427 shares were bought by its insiders, resulting in a net sale of 110,854 shares.

Heliogen Inc (HLGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Heliogen Inc Insider Transactions

No Available Data

What does Athena Technology Acquisition Corp do?

Who are the key executives at Athena Technology Acquisition Corp?

Nant Capital, Llc is the 10 percent owner of Athena Technology Acquisition Corp. Other key executives at Athena Technology Acquisition Corp include CFO and Head of Strategy Sagar Kurada , 10 percent owner Prime Movers Lab Fund Ii Lp , and Interim CFO & and CAO Kelly Rosser .

Athena Technology Acquisition Corp (ATHN.U) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Athena Technology Acquisition Corp (ATHN.U) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Athena Technology Acquisition Corp (ATHN.U) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Athena Technology Acquisition Corp (ATHN.U)'s detailed insider trading history can be found in Insider Trading Tracker table.

Athena Technology Acquisition Corp Insider Transactions

No Available Data

What does ImmunityBio Inc do?

Who are the key executives at ImmunityBio Inc?

Nant Capital, Llc is the 10 percent owner of ImmunityBio Inc. Other key executives at ImmunityBio Inc include director & 10 percent owner & See remarks Patrick Soon-shiong , 10 percent owner California Capital Equity, Llc , and 10 percent owner Mp 13 Ventures, Llc .

ImmunityBio Inc (IBRX) Insider Trades Summary

Over the past 18 months, Nant Capital, Llc made no insider transaction in ImmunityBio Inc (IBRX). Other recent insider transactions involving ImmunityBio Inc (IBRX) include a net purchase of 71,915 shares made by Michael D Blaszyk , a net purchase of 25,000 shares made by John Owen Brennan , and a net purchase of 7,000 shares made by Wesley Clark .

In summary, during the past 3 months, insiders sold 0 shares of ImmunityBio Inc (IBRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ImmunityBio Inc (IBRX) were sold and 103,915 shares were bought by its insiders, resulting in a net purchase of 103,915 shares.

ImmunityBio Inc (IBRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

ImmunityBio Inc Insider Transactions

No Available Data

Nant Capital, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Nant Capital, Llc. You might contact Nant Capital, Llc via mailing address: 9922 Jefferson Boulevard, Culver City Ca 90232.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.